These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 26294075)

  • 21. Disease activity of idiopathic juvenile arthritis continues through adolescence despite the use of biologic therapies.
    Vidqvist KL; Malin M; Varjolahti-Lehtinen T; Korpela MM
    Rheumatology (Oxford); 2013 Nov; 52(11):1999-2003. PubMed ID: 23893666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biologics for the treatment of juvenile idiopathic arthritis: a systematic review and critical analysis of the evidence.
    Gartlehner G; Hansen RA; Jonas BL; Thieda P; Lohr KN
    Clin Rheumatol; 2008 Jan; 27(1):67-76. PubMed ID: 17570009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in body mass index in children with juvenile idiopathic arthritis treated with tumor necrosis factor inhibitors.
    Shafferman A; Fontaine KR; Cron RQ; Beukelman T
    J Rheumatol; 2014 Jan; 41(1):113-8. PubMed ID: 24293573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth and body mass index in a cohort of patients with juvenile idiopathic arthritis: effects of second line treatments.
    Marino A; Stagi S; Simonini G; Carli N; Caparello MC; Giani T; Pagnini I; De Masi S; Cimaz R
    Clin Exp Rheumatol; 2018; 36(5):929-933. PubMed ID: 30148444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New drugs for treatment of juvenile idiopathic arthritis].
    Horneff G
    Z Rheumatol; 2019 Sep; 78(7):587-598. PubMed ID: 31098699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High doses of infliximab in the management of juvenile idiopathic arthritis.
    Tambralli A; Beukelman T; Weiser P; Atkinson TP; Cron RQ; Stoll ML
    J Rheumatol; 2013 Oct; 40(10):1749-55. PubMed ID: 23950184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications.
    Ringold S; Weiss PF; Beukelman T; DeWitt EM; Ilowite NT; Kimura Y; Laxer RM; Lovell DJ; Nigrovic PA; Robinson AB; Vehe RK;
    Arthritis Rheum; 2013 Oct; 65(10):2499-512. PubMed ID: 24092554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting Which Children with Juvenile Idiopathic Arthritis Will Not Attain Early Remission with Conventional Treatment: Results from the ReACCh-Out Cohort.
    Guzman J; Henrey A; Loughin T; Berard RA; Shiff NJ; Jurencak R; Huber AM; Oen K; Gerhold K; Feldman BM; Scuccimarri R; Houghton K; Chédeville G; Morishita K; Lang B; Dancey P; Rosenberg AM; Barsalou J; Bruns A; Watanabe Duffy K; Benseler S; Duffy CM; Tucker LB;
    J Rheumatol; 2019 Jun; 46(6):628-635. PubMed ID: 30647178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biologics in Pediatric Rheumatology: Quo Vadis?
    Sterba Y; Ilowite N
    Curr Rheumatol Rep; 2016 Jul; 18(7):45. PubMed ID: 27306623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biologic drug access and juvenile idiopathic arthritis in Canada: improving collaboration between clinician experts and funders.
    Cohen E; Grill A; Coyle D
    J Rheumatol; 2013 Mar; 40(3):338. PubMed ID: 23457402
    [No Abstract]   [Full Text] [Related]  

  • 31. Update on biologics in juvenile idiopathic arthritis.
    Ilowite NT
    Curr Opin Rheumatol; 2008 Sep; 20(5):613-8. PubMed ID: 18698187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Progress in treatment of juvenile idiopathic arthritis with biologic agents].
    Ma C; Lu XY; Wu HX
    Zhonghua Er Ke Za Zhi; 2011 Jul; 49(7):519-22. PubMed ID: 22088181
    [No Abstract]   [Full Text] [Related]  

  • 33. Access to pediatric rheumatology care for Juvenile Idiopathic Arthritis in the United Arab Emirates.
    Khawaja K; Al-Maini M
    Pediatr Rheumatol Online J; 2017 May; 15(1):41. PubMed ID: 28511684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variation in Treatment of Children Hospitalized With New-Onset Systemic Juvenile Idiopathic Arthritis in the US.
    Peterson RG; Xiao R; James KE; Katcoff H; Fisher BT; Weiss PF
    Arthritis Care Res (Hoboken); 2021 Dec; 73(12):1714-1721. PubMed ID: 33242366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel therapies for the treatment of juvenile rheumatoid arthritis (juvenile idiopathic arthritis).
    Agle LM; Rosenkranz M; Lehman TJ
    Expert Opin Investig Drugs; 2003 Jan; 12(1):19-28. PubMed ID: 12517251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of Juvenile Idiopathic Arthritis: A Clinical Guide.
    Blazina Š; Markelj G; Avramovič MZ; Toplak N; Avčin T
    Paediatr Drugs; 2016 Dec; 18(6):397-412. PubMed ID: 27484749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Harnessing interactive technologies to improve health outcomes in juvenile idiopathic arthritis.
    Coda A; Sculley D; Santos D; Girones X; Brosseau L; Smith DR; Burns J; Rome K; Munro J; Singh-Grewal D
    Pediatr Rheumatol Online J; 2017 May; 15(1):40. PubMed ID: 28511689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Juvenile idiopathic arthritis--current and future therapies.
    Kahn P
    Bull NYU Hosp Jt Dis; 2009; 67(3):291-302. PubMed ID: 19852753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacosurveillance in Juvenile Idiopathic Arthritis.
    Shiff NJ; Beukelman T
    Rheum Dis Clin North Am; 2021 Nov; 47(4):643-653. PubMed ID: 34635296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Difficult-To-Treat Juvenile Idiopathic Arthritis: Current and Future Options.
    Pagnini I; Bertini F; Cimaz R
    Paediatr Drugs; 2016 Apr; 18(2):101-8. PubMed ID: 26939782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.